Bassil I Dahiyat Xencor Inc (XNCR) insider trading activity

XNCR Quotes by TradingView

Bassil I Dahiyat is PRESIDENT & CEO of Xencor Inc. Currently has a direct ownership of 375,390 shares of XNCR, which is worth approximately $6.48 Million. The most recent transaction as insider was on Feb 03, 2025, when has been sold 8,808 shares (Common Stock) at a price of $15.69 per share, resulting in proceeds of $138,197. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 375K
6.68% 3M change
19.96% 12M change
Total Value Held $6.48 Million

Bassil I Dahiyat Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
BUY
Exercise of conversion of derivative security
$138,197 $15.69 p/Share
8,808 Added 2.29%
375,390 Common Stock
Nov 22 2024
BUY
Exercise of conversion of derivative security
$212,568 $15.69 p/Share
13,548 Added 3.57%
366,163 Common Stock
Nov 21 2024
SELL
Open market or private sale
$1,186,121 $24.07 p/Share
49,278 Reduced 12.26%
352,615 Common Stock
Nov 21 2024
BUY
Exercise of conversion of derivative security
$773,171 $15.69 p/Share
49,278 Added 10.92%
401,893 Common Stock
Nov 13 2024
SELL
Open market or private sale
$80,851 $24.02 p/Share
3,366 Reduced 0.95%
352,615 Common Stock
Nov 13 2024
BUY
Exercise of conversion of derivative security
$52,812 $15.69 p/Share
3,366 Added 0.94%
355,981 Common Stock
Mar 11 2024
SELL
Open market or private sale
$64,413 $23.5 p/Share
2,741 Reduced 0.77%
351,894 Common Stock
Mar 05 2024
SELL
Open market or private sale
$293,531 $23.43 p/Share
12,528 Reduced 4.01%
300,097 Common Stock
Mar 05 2024
BUY
Grant, award, or other acquisition
-
54,538 Added 13.33%
354,635 Common Stock
Dec 29 2023
SELL
Open market or private sale
$941,850 $20.93 p/Share
45,000 Reduced 12.57%
312,929 Common Stock
Dec 29 2023
BUY
Exercise of conversion of derivative security
$718,261 $11.05 p/Share
65,001 Added 15.37%
357,929 Common Stock
Jun 21 2023
SELL
Open market or private sale
$877,286 $26.19 p/Share
33,497 Reduced 10.28%
292,216 Common Stock
Jun 21 2023
BUY
Exercise of conversion of derivative security
$323,051 $4.25 p/Share
76,012 Added 18.92%
325,713 Common Stock
Mar 09 2023
SELL
Open market or private sale
$77,747 $29.88 p/Share
2,602 Reduced 1.03%
249,701 Common Stock
Mar 06 2023
SELL
Open market or private sale
$183,210 $31.42 p/Share
5,831 Reduced 2.26%
252,303 Common Stock
Mar 03 2023
SELL
Open market or private sale
$89,920 $31.54 p/Share
2,851 Reduced 1.09%
258,134 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
52,521 Added 16.75%
260,985 Common Stock
Mar 09 2022
SELL
Open market or private sale
$72,326 $29.0 p/Share
2,494 Reduced 1.19%
207,815 Common Stock
Mar 03 2022
SELL
Open market or private sale
$87,577 $29.9 p/Share
2,929 Reduced 1.79%
160,548 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
49,761 Added 19.13%
210,309 Common Stock
Mar 08 2021
BUY
Grant, award, or other acquisition
-
21,999 Added 11.89%
163,063 Common Stock
Mar 03 2021
SELL
Open market or private sale
$127,908 $44.88 p/Share
2,850 Reduced 1.98%
141,064 Common Stock

Also insider at

KOD
Kodiak Sciences Inc. Healthcare
BID

Bassil I Dahiyat

PRESIDENT & CEO
Palo Alto, CA

Track Institutional and Insider Activities on XNCR

Follow Xencor Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XNCR shares.

Notify only if

Insider Trading

Get notified when an Xencor Inc insider buys or sells XNCR shares.

Notify only if

News

Receive news related to Xencor Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XNCR